Lewy Body Disease Clinical Trial
Official title:
Lewy Body Spectrum Disorders: Investigating Neuropsychiatric Benefit and Adverse Effects in Response to Cholinesterase Inhibitors Using Genetics and Brain SPECT
Lewy body spectrum disorders are a common group of neurodegenerative diseases that cause memory loss, behavioural and motor disabilities that impair quality of life. Cognitive enhancers help people afflicted with these conditions. However, some people do not benefit from this treatment, while others experience serious side effects. Side effects and poor response lead to hospitalization and early institutionalization. Pharmacogenomics, the study of how DNA variation can influence drug effects, will be combined with functional changes in brain imaging in response to cognitive enhancers in patients with Lewy body disease. The goal is to develop a predictive test that can be administered in the clinic to aid physicians' choice of initial medication. This can reduce health care costs and improve treatment to Canadians suffering from these devastating disorders.
n/a
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04436341 -
Epileptic Activity in Patients With Alzheimer's Disease and Lewy Body Dementia
|
||
Not yet recruiting |
NCT05004558 -
Effects of Remote-based Resistance Training on Cardiometabolic Risk Factors, Cognitive Function, and Quality of Life in Adults Living With Alzheimer's Disease and/or Related Dementias
|
N/A | |
Enrolling by invitation |
NCT03724136 -
Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment Study
|
N/A | |
Terminated |
NCT02263287 -
LESCOD: "Lewy Body Screening in Cognitive Disorders"
|
N/A | |
Completed |
NCT05188105 -
Alpha tACS in Dementia With Lewy Bodies
|
N/A | |
Completed |
NCT04649164 -
Learning to PERSEVERE: Peer Mentor Support and Caregiver Education in Lewy Body Dementia
|
N/A | |
Active, not recruiting |
NCT04148391 -
NYX-458 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's Disease or Lewy Body Dementia (Cognition, Memory, Attention, Thinking)
|
Phase 2 | |
Recruiting |
NCT06203106 -
NYSCF Scientific Discovery Biobank
|
||
Enrolling by invitation |
NCT05514106 -
MIBG in Aging and Neurologic Disorders
|
Phase 4 | |
Recruiting |
NCT04817891 -
Stimulation of Cingulo-opercular Alertness Network
|
N/A | |
Completed |
NCT05916664 -
Efficacy Study of Kinto Care Coaching for Dementia Family Caregivers
|
N/A | |
Recruiting |
NCT03174938 -
The Swedish BioFINDER 2 Study
|
N/A | |
Recruiting |
NCT06389032 -
PERSEVERE: Peer Mentor Support and Caregiver Education in Lewy Body Dementia
|
N/A | |
Recruiting |
NCT05847985 -
Language and Lewy Body Diseases: Sentence Comprehension Problems and Modifying Noninvasive Brain Stimulation Treatment
|
N/A | |
Completed |
NCT04794634 -
Relationship Between Alzheimer Disease and Diminution of the Three Macular Nervous Retinal Layers
|
N/A | |
Recruiting |
NCT03472482 -
Optical Coherence Tomography in Cerebral Amyloidosis
|
||
Not yet recruiting |
NCT00448318 -
Evaluating the Effects of Music Interventions on Hospitalised People With Dementia
|
Phase 2/Phase 3 | |
Completed |
NCT04287738 -
Care Ecosystem: Navigating Patients and Families Through Stages of Care, Extension Trial
|
N/A | |
Completed |
NCT02213458 -
Care Ecosystem: Navigating Patients and Families Through Stages of Care
|
N/A | |
Completed |
NCT03076671 -
More Than a Movement Disorder: Applying Palliative Care to Parkinson's Disease
|
N/A |